Immune-mediated inflammatory diseases

Immune-mediated inflammatory diseases (IMIDs) are a group of conditions that occur when the immune system mistakenly attacks the body's own tissues, leading to inflammation. These diseases can affect almost any part of the body, including the joints, skin, gastrointestinal tract, and nervous system. Common examples of IMIDs include rheumatoid arthritis, psoriasis, inflammatory bowel disease (including Crohn's disease and ulcerative colitis), and multiple sclerosis.

Causes and Pathogenesis

The exact causes of IMIDs are not fully understood, but they are believed to result from a combination of genetic and environmental factors. Genetically, certain individuals have a predisposition to develop these conditions, which can be triggered by environmental factors such as infections, physical trauma, or exposure to certain chemicals. The pathogenesis of IMIDs involves the dysregulation of the immune system, where the body's defense mechanisms mistakenly target healthy tissues, leading to chronic inflammation and tissue damage.

Symptoms

The symptoms of IMIDs vary widely depending on the specific disease and the organs involved but generally include signs of inflammation such as redness, swelling, pain, and loss of function. For example, rheumatoid arthritis primarily affects the joints, leading to painful swelling and potential joint deformity, while psoriasis causes itchy, scaly skin patches.

Diagnosis

Diagnosis of IMIDs typically involves a combination of clinical evaluation, laboratory tests, and imaging studies. Blood tests may reveal markers of inflammation or specific antibodies associated with certain conditions. Imaging tests, such as X-rays or MRI, can help assess the extent of organ involvement and damage.

Treatment

Treatment of IMIDs aims to reduce inflammation, alleviate symptoms, and prevent organ damage. This may include the use of anti-inflammatory drugs, immunosuppressive medications, and biologic agents that specifically target components of the immune system. Physical therapy and lifestyle modifications may also be recommended to manage symptoms and improve quality of life.

Prognosis

The prognosis of IMIDs varies depending on the specific disease, its severity, and the effectiveness of treatment. While these conditions are generally chronic and incurable, appropriate management can help control symptoms, reduce the risk of complications, and improve outcomes.

Epidemiology

IMIDs collectively affect a significant portion of the population worldwide. The prevalence of each disease varies, with conditions like psoriasis and rheumatoid arthritis being relatively common, while others, such as certain types of vasculitis, are rarer.

See Also

• Autoimmune disease
• Chronic inflammation
• Biologic therapy

References

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian